Skip to main content
Top
Published in: European Journal of Pediatrics 1/2010

01-01-2010 | Review

Clinical practice

The impact of lung disease on the heart and cardiac disease on the lungs

Authors: Fiona Healy, Brian D. Hanna, Raezelle Zinman

Published in: European Journal of Pediatrics | Issue 1/2010

Login to get access

Abstract

Pathologies in both the respiratory and cardiovascular systems frequently coexist and impact on each other. This manuscript introduces an approach to the interpretation of this complex relationship. Pulmonary hypertension can be a significant consequence of many respiratory diseases. This in turn can lead to right ventricular dysfunction and cor pulmonale. Many childhood illnesses can result in cor pulmonale and can be conveniently grouped into three categories: idiopathic pulmonary hypertension, neonatal lung diseases, and lung disease beyond the neonatal period. When considering the impact of cardiac disease on the lung, one must consider two main pathologies: compression of the pediatric airway and increased lung water. In conclusion, thorough attention must be given to the interpretation of the complex relationship between cardiac and respiratory diseases. Pulmonary hypertension is a complication to consider in respiratory illness at all ages. In addition, when dealing with the complexities of congenital heart disease, one must always be aware of the risks of pulmonary complications whether parenchymal or airway. Ongoing improvements in ventilation strategies, vasodilator therapy, and surgical interventions continue to improve the outlook for these complex cases.
Literature
1.
go back to reference Alzeer AH, Al-Mobeirek AF, Al-Otair HA et al (2008) Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis. Chest 133(2):468–473CrossRefPubMed Alzeer AH, Al-Mobeirek AF, Al-Otair HA et al (2008) Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis. Chest 133(2):468–473CrossRefPubMed
2.
go back to reference Ambrusko SJ, Gunawardena S, Sakara A et al (2006) Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Pediatr Blood Cancer 47(7):907–913CrossRefPubMed Ambrusko SJ, Gunawardena S, Sakara A et al (2006) Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Pediatr Blood Cancer 47(7):907–913CrossRefPubMed
3.
go back to reference Bernus A, Wagner BD, Accurso F et al (2009) Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension. Chest 135(3):745–751CrossRefPubMed Bernus A, Wagner BD, Accurso F et al (2009) Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension. Chest 135(3):745–751CrossRefPubMed
4.
go back to reference Blanch L, Bernabe F, Lucangelo U (2005) Measurement of air trapping, intrinsic positive end-expiratory pressure and dynamic hyperinflation in mechanically ventilated patients. Respir Care 50(1):110–123PubMed Blanch L, Bernabe F, Lucangelo U (2005) Measurement of air trapping, intrinsic positive end-expiratory pressure and dynamic hyperinflation in mechanically ventilated patients. Respir Care 50(1):110–123PubMed
5.
go back to reference Cecconi M, Johnston E, Rhodes A (2006) What role does the right side of the heart play in circulation? Crit Care 10(Suppl 3):S5CrossRefPubMed Cecconi M, Johnston E, Rhodes A (2006) What role does the right side of the heart play in circulation? Crit Care 10(Suppl 3):S5CrossRefPubMed
6.
go back to reference Cool CD, Deutsch G (2008) Pulmonary arterial hypertension from a pediatric perspective. Pediatr Dev Pathol 11(3):169–177CrossRefPubMed Cool CD, Deutsch G (2008) Pulmonary arterial hypertension from a pediatric perspective. Pediatr Dev Pathol 11(3):169–177CrossRefPubMed
7.
go back to reference De Wolf D (2009) Clinical practice: pulmonary hypertension in children. Eur J Pediatr 168:515–522CrossRefPubMed De Wolf D (2009) Clinical practice: pulmonary hypertension in children. Eur J Pediatr 168:515–522CrossRefPubMed
8.
go back to reference Dimopoulos K, Giannakoulas G, Wort SJ, Gatzoulis MA (2008) Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications. Curr Opin Cardiol 23(6):545–554CrossRefPubMed Dimopoulos K, Giannakoulas G, Wort SJ, Gatzoulis MA (2008) Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications. Curr Opin Cardiol 23(6):545–554CrossRefPubMed
9.
go back to reference Eckles M, Anderson P (2003) Cor pulmonale in cystic fibrosis. Semin Respir Crit Care Med 24(3):323–330CrossRefPubMed Eckles M, Anderson P (2003) Cor pulmonale in cystic fibrosis. Semin Respir Crit Care Med 24(3):323–330CrossRefPubMed
10.
go back to reference Engelfriet PM, Duffels MG, Möller T, Boersma E et al (2007) Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 93(6):682–687CrossRefPubMed Engelfriet PM, Duffels MG, Möller T, Boersma E et al (2007) Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 93(6):682–687CrossRefPubMed
11.
go back to reference Farhath S, He Z, Nakhla T et al (2008) Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatrics 121(2):e253–e259CrossRefPubMed Farhath S, He Z, Nakhla T et al (2008) Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatrics 121(2):e253–e259CrossRefPubMed
12.
go back to reference Kussman BD, Geva T, McGowan FX (2004) Cardiovascular causes of airway compression. Paediatr Anaesth 14(1):60–74CrossRefPubMed Kussman BD, Geva T, McGowan FX (2004) Cardiovascular causes of airway compression. Paediatr Anaesth 14(1):60–74CrossRefPubMed
13.
go back to reference Lambert P, Sloth E, Smith B et al (2007) Does a positive end-expiratory pressure-induced reduction in stroke volume indicate preload responsiveness? An experimental study. Acta Anaesthesiol Scand 51:415–425CrossRefPubMed Lambert P, Sloth E, Smith B et al (2007) Does a positive end-expiratory pressure-induced reduction in stroke volume indicate preload responsiveness? An experimental study. Acta Anaesthesiol Scand 51:415–425CrossRefPubMed
14.
go back to reference Lee MT, Berman Rosenzweig EB, Cairo MS (2007) Pulmonary hypertension in sickle cell disease. Clin Adv Hematol Oncol 5(8):645–653 585PubMed Lee MT, Berman Rosenzweig EB, Cairo MS (2007) Pulmonary hypertension in sickle cell disease. Clin Adv Hematol Oncol 5(8):645–653 585PubMed
15.
go back to reference Onyekwere OC, Campbell A, Teshome M et al (2008) Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol 29(2):309–312CrossRefPubMed Onyekwere OC, Campbell A, Teshome M et al (2008) Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol 29(2):309–312CrossRefPubMed
16.
go back to reference Simonneau G, Gale N, Rubin LJ et al (2004) Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43:5S–12SCrossRefPubMed Simonneau G, Gale N, Rubin LJ et al (2004) Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43:5S–12SCrossRefPubMed
Metadata
Title
Clinical practice
The impact of lung disease on the heart and cardiac disease on the lungs
Authors
Fiona Healy
Brian D. Hanna
Raezelle Zinman
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 1/2010
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-009-1027-8

Other articles of this Issue 1/2010

European Journal of Pediatrics 1/2010 Go to the issue